BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10515324)

  • 1. Discriminative stimulus properties of eltoprazine in the pigeon.
    Olivier B; Herremans A; Mos J; van Drimmelen M; Tulp M; van Oorschot R; Hijzen T
    Pharmacol Biochem Behav; 1999 Oct; 64(2):421-7. PubMed ID: 10515324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of the serotonergic compound eltoprazine.
    Ybema CE; Slangen JL; Olivier B; Mos J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190.
    Barrett JE; Gleeson S
    Eur J Pharmacol; 1992 Jul; 217(2-3):163-71. PubMed ID: 1425937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus properties of eltoprazine.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Life Sci; 1997; 61(1):11-9. PubMed ID: 9200664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.
    Herremans AH; van der Heyden JA; van Drimmelen M; Olivier B
    Pharmacol Biochem Behav; 1999 Oct; 64(2):389-95. PubMed ID: 10515319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent discriminative stimulus properties of 8-OH-DPAT.
    Ybema CE; Slangen JL; Olivier B; Mos J
    Behav Pharmacol; 1993 Dec; 4(6):610-624. PubMed ID: 11224230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
    De Vry J; Jentzsch KR
    Eur J Pharmacol; 1998 Sep; 357(1):1-8. PubMed ID: 9788767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-lever drug-drug discrimination with the 5-HT1 receptor agonists flesinoxan and eltoprazine.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Int J Neuropsychopharmacol; 2000 Sep; 3(3):221-228. PubMed ID: 11343599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
    Herndon JL; Pierson ME; Glennon RA
    Pharmacol Biochem Behav; 1992 Nov; 43(3):739-48. PubMed ID: 1333084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effect of flesinoxan: effect of 5-HT1A antagonists and PCPA.
    Ybema CE; Slangen JL; Olivier B
    Pharmacol Biochem Behav; 1994 Apr; 47(4):957-62. PubMed ID: 8029269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CP-135,807, a selective 5-HT1D agonist: effects in drug discrimination and punishment procedures in the pigeon.
    Mansbach RS; Rovetti CC; Macor JE
    Psychopharmacology (Berl); 1996 Dec; 128(3):313-9. PubMed ID: 8972551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences.
    Kleven MS; Koek W
    J Pharmacol Exp Ther; 1998 Jan; 284(1):238-49. PubMed ID: 9435184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of 5-HT1A receptor ligands by drug discrimination.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MP-3022 on the 8-OH-DPAT-induced discriminative stimulus in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1996; 48(4):397-402. PubMed ID: 9112679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full substitution of the discriminative cue of a 5-HT(1A/1B/2C) agonist with the combined administration of a 5-HT(1B/2C) and a 5-HT(1A) agonist.
    Miranda F; Orozco G; Velázquez-Martínez DN
    Behav Pharmacol; 2002 Jul; 13(4):303-11. PubMed ID: 12218511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.